We have been instrumental in the discovery of four drugs now on the market
We leverage our accomplishments in drug discovery with our determination to remain at the cutting edge of research to deliver innovation for industry and academia. As your partner, we provide you with robust and cutting edge scientific expertise, honed in global pharma, along with the steadfast support required in a fast-paced and challenging industry.
Science is our cornerstone. Our unprecedented track record in discovering drugs demonstrates this. We capitalize on our shared enthusiasm for innovative R&D, spurred on by our dedication to deliver excellence at every opportunity.
Our expertise spans different modalities including small molecule, peptide and biologic therapeutics. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
Our partners are of the utmost importance. We always strive to go above and beyond your expectations, treating your projects as our highest priority.
We offer a unique blend of broad scientific expertise, global pharma heritage, and unprecedented success in bringing drug discovery projects from conception to the clinic. With a passionate, interdisciplinary and accomplished team, and capabilities ranging from target validation to clinical candidate nomination, we bring great science to your project.
Heidi Kingdon Jones, our Global Vice President of Sales & Marketing, and Esther Torrente, Research Chemist, will be attending the 27th International Symposium on Medicinal Chemistry, run by the EFMC in Nice, France from 4-8 September.
The IRBM peptide chemistry team is proud to announce a new publication in ACS Medicinal Chemistry Letters in collaboration with the outstanding drug discovery team at Merck & Co. (Kenilworth, NJ).
The Power of NMR in Drug Discovery
Structural biology (SB) provides a critical drug discovery and development tool for accurately identifying and understanding the structure of a target. Alessandro Piai, PhD, Principal Research Scientist at IRBM, describes the company’s expertise in nuclear magnetic resonance (NMR) and how it can be leveraged to accelerate the identification of molecules for progression to the clinic.
Privacy & Cookies Policy
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
Set by Google to distinguish users.
Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Vimeo installs this cookie to collect tracking information by setting a unique ID to embed videos to the website.